Left Atrial Appendage Closure Recruiting Phase 4 Trials for Dabigatran (DB14726)

IndicationStatusPhase
DBCOND0074424 (Left Atrial Appendage Closure)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03568890Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage ClosurePrevention